BFC Planning’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
BFC Planning's LKFT Position: Q3 2026 in Review
BFC Planning held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q3 2026 at 3 shares worth $89. The position accounts for ﹤0.01% of the portfolio, ranked #3395.
BFC Planning first reported a position in LKFT in Q2 2026 and has held it in 2 quarters since. The position peaked at $90 in Q2 2026. 67 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- BFC Planning held 3 shares of Lakefront Biotherapeutics American Depositary Shares worth $89 as of Q3 2026.
- BFC Planning left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3395 holding.
- BFC Planning first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2026 and has held it in 2 quarters since.
- BFC Planning's Lakefront Biotherapeutics American Depositary Shares position peaked at $90 in Q2 2026.
- 67 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.